dsm-firmenich Animal Nutrition & Health have reached a pivotal regulatory step following the European Food Safety Authority’s (EFSA) published scientific opinion confirming the safety and efficacy of 25-hydroxycholecalciferol (25-OH-D₃) exclusively produced with Saccharomyces cerevisiae CBS 146008 for salmonids, other fish species, and all other animal species. The confirmation extends the recognized safety and efficacy of Hy-D® beyond poultry, swine, and ruminants to the entire spectrum of terrestrial and aquatic animals.
Hy-D®, an innovative vitamin D3 metabolite, supports optimal levels of 25-OH-D₃, providing all-round benefits in animal health and performance.
Emrah Mazi, Head of Special Nutrients at dsm-firmenich Animal Nutrition & Health said, “This opinion from ESFA marks a key milestone for Hy-D®, demonstrating its global relevance and potential as a reliable source of vitamin D across all animal species. We are excited about what this means for the future of Hy-D® in helping customers around the world advance animal health and performance with confidence’.
Hy-D® offers significant benefits for animals, including health and welfare, performance and productivity, and overall food quality. Proper usage of Hy-D® can positively impact animal wellbeing and productivity.
Final authorization from the European Commission remains pending and is expected to take several months. Subject to approval, Hy-D® could be available for use in the EU for aquaculture and all other animal species by early 2026.
This milestone advances the company’s mission to deliver safe, effective, and sustainable nutritional solutions, bringing Hy-D® one step closer to its full species-wide potential.
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.
www.dsm-firmenich.com
This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
07 July 2025
Get in touch with a dsm-firmenich Animal Nutrition & Health specialist or find contacts around the world to suit your needs.
At dsm-firmenich, we love to connect with you.
Follow us on any of the channels below.
We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.
